Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
CiToxLAB
CiToxLAB
Activities:
Regulatory
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
CiToxLAB hires Alan Bartlett as Senior Director, Global Laboratory Operations
Bartlett will be based at the contract research organisation's Laval site in North America
Research & Development
CiToxLAB hires Senior Director of Biomarkers
Philippe Ancian returns to the French contract research organisation
Research & Development
CiToxLAB appoints John Kapeghian as Senior Director of Toxicology in North America
Boosts company’s expertise in preclinical development and regulatory affairs
Research & Development
CiToxLAB expands inhalation test capabilities in North America and Europe
Opens rodent and non-rodent facility in Canada and will double rodent capacity in Hungary
Research & Development
CiToxLAB increases capabilities in reprotoxicology and juvenile studies
Appoints Paul Barrow as director of scientific projects and client consulting
Regulatory
CiToxLAB emerges from CIT and LAB Research merger
Will provide pre-clinical and specialist services from four facilities
Regulatory
CIT acquires assets of LAB Research Inc
This acquisition makes the new group one of the world’s top preclinical CROs
Subscribe now